vTv Therapeutics, Inc. (VTVT)
33.89
+0.64
(+1.91%)
USD |
NASDAQ |
Aug 24, 16:00
33.61
-0.28
(-0.83%)
After-Hours: 20:00
vTv Therapeutics Shareholders Equity (Quarterly) : 78.63M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.63M |
| March 31, 2026 | 89.96M |
| December 31, 2025 | 64.44M |
| September 30, 2025 | 70.54M |
| June 30, 2025 | 2.762M |
| March 31, 2025 | 7.92M |
| December 31, 2024 | 12.20M |
| September 30, 2024 | 15.01M |
| June 30, 2024 | 16.48M |
| March 31, 2024 | 20.80M |
| December 31, 2023 | -24.68M |
| September 30, 2023 | -25.23M |
| June 30, 2023 | -25.28M |
| March 31, 2023 | -19.19M |
| December 31, 2022 | -10.74M |
| September 30, 2022 | -12.57M |
| June 30, 2022 | -8.526M |
| March 31, 2022 | -8.093M |
| December 31, 2021 | -9.74M |
| September 30, 2021 | -21.54M |
| June 30, 2021 | -47.82M |
| March 31, 2021 | -56.28M |
| December 31, 2020 | -80.10M |
| Date | Value |
|---|---|
| September 30, 2020 | -51.37M |
| June 30, 2020 | -69.53M |
| March 31, 2020 | -61.82M |
| December 31, 2019 | -49.02M |
| September 30, 2019 | -47.15M |
| June 30, 2019 | -49.90M |
| March 31, 2019 | -57.74M |
| December 31, 2018 | -82.85M |
| September 30, 2018 | -43.98M |
| June 30, 2018 | -71.60M |
| March 31, 2018 | -148.79M |
| December 31, 2017 | -151.05M |
| September 30, 2017 | -136.30M |
| June 30, 2017 | -106.41M |
| March 31, 2017 | -123.47M |
| December 31, 2016 | -90.94M |
| September 30, 2016 | -111.24M |
| June 30, 2016 | -79.52M |
| March 31, 2016 | -63.02M |
| December 31, 2015 | -77.97M |
| September 30, 2015 | -94.18M |
| June 30, 2015 | -594.11M |
| March 31, 2015 | 26.08M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 1.101B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.59M |
| Total Liabilities (Quarterly) | 8.961M |
| Current Ratio | 12.48 |
| Net Debt Paydown Yield | 0.02% |